Phase 1/2 and extension study of velaglucerase alfa replacement therapy in adults with type 1 Gaucher disease: 48-month experience

Autor: Zimran, Ari, Altarescu, Gheona, Philips, Mici, Attias, Drorit, Jmoudiak, Marina, Deeb, Maher, Wang, Nan, Bhirangi, Kiran, Cohn, Gabriel M., Elstein, Deborah *
Zdroj: In Blood 10 June 2010 115(23):4651-4656
Databáze: ScienceDirect